Market Access/ News/ News J&J seeks wider use of its Spravato antidepressant in US Phil Taylor anti, central nervous system, depression, Johnson & Johnson, Psychiatry, Spravato 0 Comment Johnson & Johnson has filed for US approval for a new claim on the label for its nasal Share X J&J seeks wider use of its Spravato antidepressant in US https://pharmaphorum.com/news/jj-seeks-wider-use-of-its-spravato-antidepressant-in-us/
anti, central nervous system, depression, Johnson & Johnson, Psychiatry, Spravato
0 Comment
